Latest Breaking News On - Finished product manufacturing site - Page 1 : comparemela.com

EMA Says Increase In Vaccine Manufacturing Capacity, Supply For COVID-19 Vaccines From Biontech/Pfizer & Moderna Published: 04/23/2021 12:47 GMT Moderna Inc (MRNA) - Ema Says Increase in Vaccine Manufacturing Capacity and Supply for Covid-19 Vaccines From Biontech/pfizer and Moderna. Ema - Approved an Increase in Batch Size and Associated Process Scale Up at Pfizer’s Vaccine Manufacturing Site in Puurs, Belgium. Ema Says Ema Has Approved an Increase in Batch Size and Associated Process Scale Up at Pfizer s Vaccine Manufacturing Site in Puurs, Belgium . Ema Says Chmp Also Recommended Approval of a New Filling Line at Moderna s Finished Product Manufacturing Site for Eu in Rovi, Spain .

Region flamandeEuropean unionModerna incSays increaseVaccine manufacturing capacityBatch sizeVaccine manufacturing siteSays ema has approvedSays chmp also recommended approvalNew filling lineFinished product manufacturing siteSays recommendationChmp expectedHave significant impactSays decision reaffirms puurs facility capableConsistently producing high quality vaccines